Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Short-term Investments (2024 - 2025)

Precision Biosciences (DTIL) has disclosed Short-term Investments for 1 consecutive years, with $413000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Short-term Investments changed N/A to $413000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $413000.0, a N/A change, with the full-year FY2024 number at $413000.0, changed N/A from a year prior.
  • Short-term Investments was $413000.0 for Q4 2024 at Precision Biosciences, down from $2.4 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $2.4 million in Q3 2024 to a low of $413000.0 in Q4 2024.